Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerBlood-Borne Infections, Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, HIV infectious disease, Infections, Neoplasms by Site, RNA Virus Infections, Urogenital Diseases, anal margin squamous cell carcinoma, anal squamous cell carcinoma, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, immune system disorder, inborn error of immunity, infectious disease, intestinal disorder, lentivirus infection, neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, squamous cell carcinoma of rectum, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingPhase 22026-10-05NCT04929028

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
George Washington University Medical CenterWashington D.C.United States52
Icahn School of Medicine at Mount SinaiNew YorkUnited States342
Lyndon Baines Johnson General HospitalHoustonUnited States36
Moffitt Cancer CenterTampaUnited States523
Montefiore Medical Center - Moses CampusThe BronxUnited States219
Montefiore Medical Center-Einstein CampusThe BronxUnited States170
Mount Sinai HospitalNew YorkUnited States225
Mount Sinai WestNew YorkUnited States78
Pennsylvania HospitalPhiladelphiaUnited States47
University of IllinoisChicagoUnited States238
UT MD Anderson Cancer CenterHoustonUnited States204
Virginia Mason Medical CenterSeattleUnited States111
Washington University School of MedicineSt LouisUnited States895
Zuckerberg San Francisco General HospitalSan FranciscoUnited States42